Key Highlights
•
A large study in Ethiopia found that women who experienced a potentially life-threatening condition during pregnancy or childbirth had significantly higher levels of disability six months later, compared to women who did not. This shows that the health impacts of a difficult pregnancy can last far longer than the traditional six-week recovery period, highlighting the need for longer-term follow-up care for mothers.
Source →
•
A nationwide study in Japan found that lung cancer patients who also had a pre-existing lung scarring disease (interstitial lung disease) lived significantly longer when treated with immunotherapy drugs compared to standard chemotherapy. This is important because doctors have been cautious about using these powerful drugs in such patients due to safety concerns, but the survival benefit appears to outweigh the risks.
Source →
•
A real-world study of over 250 Alzheimer’s patients in China found that the drug lecanemab was effective at slowing cognitive decline and was generally well-tolerated. This provides crucial evidence that this newer Alzheimer’s treatment, which targets amyloid protein in the brain, can work safely in diverse patient populations outside of tightly controlled clinical trials.
Source →
•
Researchers identified a new genetic cause for a rare, painful bone inflammation disorder in children, tracing it to a deficiency in a protein called OGFRL1. Importantly, the child in the study responded well to treatment with a common anti-inflammatory drug (a TNF inhibitor), offering a potential targeted therapy for others with this hard-to-treat condition.
Source →
•
A new analysis calls for doctors to consider testing for a specific gene variant (in SLC12A6) in all patients suspected of having an inherited nerve disorder like Charcot-Marie-Tooth disease. This is because what was once thought to be an extremely rare cause is now being found more frequently, and identifying it can lead to a more accurate diagnosis for many patients.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
